Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...
Unlocking Progress in Headache and Sleep Clinical Research in a Q&A with Dr. Sonia QuintasÂ
Medpace is proud to welcome Dr. Sonia Quintas, an accomplished and board-certified Neurologist, to our medical leadership team. Dr. Quintas brings nearly a decade of...
Medpace Expands Medical Leadership Team with Expert in Parkinson’s DiseaseÂ
Neuroscience and Cognition and brings extensive expertise in the design and execution of Parkinson’s disease research. Additionally, she has over...
Exciting CNS Breakthroughs: Where the Promise Lies
In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 1
In Part 1 of a 3 part blog series, we will explore how the heritability of neurological diseases and psychiatric diseases is changing the clinical…